ExploreWatchlistsPricing
  1. JP-listed companies
  2. PeptiDream Inc.
  3. Financials
  4. Operating margin (%)

PeptiDream Inc. (4587)

Market cap
¥157.4B
P/E ratio
Peptidream develops new drugs using its proprietary PDPS platform and creates radiopharmaceuticals for diagnosing and treating cancer and other diseases.
SummaryFinancialsDividendsHistorySegmentsOwnershipWorkforce
Period EndOperating margin (%) YoY (%)
Dec 31, 2025-27.1-159.84%
Dec 31, 202445.2+91.76%
Dec 31, 202323.6-29.46%
Dec 31, 202233.4-29.11%
Dec 31, 202147.2-21.21%
Dec 31, 202059.9-170.01%
Dec 31, 2019-85.5-272.41%
Jun 30, 201949.6+9.52%
Jun 30, 201845.3-10.96%
Jun 30, 201750.9-13.60%
Jun 30, 201658.9+4.73%
Jun 30, 201556.2+128.63%
Jun 30, 201424.6

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating expenses Operating income Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSDividend payout ratio (%)Dividend per shareEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)
AI Chat